<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tropicalmed-04-00053-t003" orientation="portrait" position="float">
 <object-id pub-id-type="pii">tropicalmed-04-00053-t003_Table 3</object-id>
 <label>Table 3</label>
 <caption>
  <p>Targeted collaboration criteria. BVGH’s partnering process emphasizes development of collaborations that meet critical healthcare needs in LMICs and are likely to result in products that reach patients.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">#</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Criterion</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Rationale</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Advanced stage of development (typically preclinical or later)</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Advanced-stage collaborations have higher chances of successfully completing all phases of development.</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Addresses an unmet medical need</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Such projects have greater likelihood of receiving funding or being transferred to an appropriate partner, such as a PDP or company, for continued development.</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Novel target or approach</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Such collaborations have greater potential to lead to innovative products that address unmet needs.</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aligns with published target product profiles (TPPs) or target candidate profiles (TCPs) (e.g., [
     <xref rid="B21-tropicalmed-04-00053" ref-type="bibr">21</xref>,
     <xref rid="B22-tropicalmed-04-00053" ref-type="bibr">22</xref>])
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TPPs and TCPs define experts’ standards and expected needs for on-the-ground product use. By aligning with TPP or TCP criteria, a product is more likely to meet experts’ standards and be accessible and acceptable for use in endemic regions.</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exemplifies the use of IP as an enabler of innovation, or demonstrates a company’s commitment to improving access to medicines</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WIPO Re:Search has two core goals: to accelerate product development for diseases of poverty, and to demonstrate that IP is not a barrier to access to medicines. Projects that fulfill this criterion exemplify the latter goal.</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
